Hormetic Stress Biohacking Type 1 Diabetes CGM

Image
Photo: Unsplash.com Medical Disclaimer : The content on this blog is purely for informational purposes only. For medical advice, diagnosis and treatment, consult your doctor. The ultimate goal for anyone living with Type 1 Diabetes (T1D) is stability. You want fewer spikes, fewer crashes, and more time spent in your target blood sugar range. Read more on blood sugar spike . For years, standard medical advice focused purely on matching insulin doses to carbohydrate intake. While this foundational math is necessary, it often leaves people riding a frustrating blood sugar roller coaster. Today, a new wave of tech-savvy individuals is looking beyond the traditional playbook. They are combining the principles of biohacking, the physiological benefits of hormetic stress, and the real-time data of Continuous Glucose Monitors (CGMs) to transform how they manage their health. This approach does not replace insulin. Instead, it aims to make the body more resilient, predictable, and res...

FDA Approves First Cellular Therapy to Treat Patients With Severe Aplastic Anemia

 The U.S. Food and Drug Administration (FDA) has announced it has approved Omisirge (omidubicel-onlv), the hematopoietic stem cell transplant (HSCT) Therapy to treat patients with severe aplastic anemia (SAA).

Omisirge is indicated for adults and pediatric patients 12 years and older with hematologic malignancies and now is approved for adults and patients six years and older with SAA following reduced intensity conditioning and for whom a compatible donor is not available.

"This approval is revolutionary in the therapeutic landscape and fundamentally changes how we approach treatment for SAA, where earlier treatment has potential to alter one's life course," Vinay Prasad, M.D., Chief Medical and Scientific Officer and Director of FDA's Center for Biologics Evaluation Research.

"Severe aplastic anemia is a rare blood disorder that can be fatal, and the FDA remains committed to expanding treatment options for patients with this disease."

SOURCE: U.S. FDA


Comments

Popular posts from this blog

The Impressive Health Benefits of Pumpkin Seeds

The Grave Consequences of Attacking Health Sites in Iran

Why Gastric Ulcer Patients Should Avoid Tomatoes and Tomato-Based Products